華寶國際(0336.HK)暴漲30% 6個交易日一度累漲超150%
格隆匯7月7日丨電子煙設備製造商思摩爾國際(6969.HK)6月29日開始公開招股,港股市場電子煙概念股華寶國際(0336.HK)和附屬公司華寶股份(300741.SZ)6月29日開始啟動上漲行情(至今6個交易日)。華寶股份今日再度漲停,最近6個交易日收出4個漲停板,累漲56%。華寶國際今日盤中一度大漲近40%至7.69港元,創逾9年新高,最近6個交易日一度累漲超150%。思摩爾國際預計於7月10日在港交所掛牌上市。注:港股市場電子煙概念股雄岸科技(1647.HK)目前漲超5%,中煙香港(6055.HK)漲超7%。


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.